In certain types of cancers, like melanomas and gliomas, SPARC is associated with a highly aggressive tumor phenotype [9], whereas in other cancers, mainly ovarian, neuroblastomas, colorectal and PNET tumors, SPARC may function as a tumor suppressor [9], [12]. This evidence concerns the gene SPARC and primitive neuroectodermal tumor.